The FOsmetpantotenate Replacement Therapy (FORT) Randomized, Double-Blind, Placebo-Controlled Pivotal Trial: Study Design and Development Methodology of a Novel Primary Efficacy Outcome in Patients With Pantothenate Kinase-Associated Neurodegeneration
Clinical Trials - United Kingdom
doi 10.1177/1740774519845673
Full Text
Open PDFAbstract
Available in full text
Date
May 6, 2019
Authors
Publisher
SAGE Publications